Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)
 
 • Company Description   
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

Number of Employees: 459

 
 • Price / Volume Information   
Yesterday's Closing Price: $6.06 Daily Weekly Monthly
20 Day Moving Average: 132,245 shares
Shares Outstanding: 40.81 (millions)
Market Capitalization: $247.31 (millions)
Beta: 1.75
52 Week High: $8.75
52 Week Low: $3.87
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.40% -12.21%
12 Week -12.93% -15.13%
Year To Date -14.04% -12.14%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
84 OCTOBER HILL RD
-
HOLLISTON,MA 01746
USA
ph: 508-893-8999
fax: 508-429-5732
info@harvardbioscience.com http://www.harvardbioscience.com
 
 • General Corporate Information   
Officers
James Green - Chief Executive Officer and Director
Michael A. Rossi - Chief Financial Officer
Katherine A. Eade - Director
Alan Edrick - Director
John F. Kennedy - Director

Peer Information
Harvard Bioscience, Inc. (DNEX)
Harvard Bioscience, Inc. (T.PUR)
Harvard Bioscience, Inc. (CALP)
Harvard Bioscience, Inc. (CCSI.)
Harvard Bioscience, Inc. (NEWP.)
Harvard Bioscience, Inc. (MTD)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: INSTRU-SCIENTFC
Sector: Computer and Technology
CUSIP: 416906105
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 03/09/22
Share - Related Items
Shares Outstanding: 40.81
Most Recent Split Date: (:1)
Beta: 1.75
Market Capitalization: $247.31 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.30 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.20
Trailing 12 Months: 35.65
PEG Ratio: -
Price Ratios
Price/Book: 3.21
Price/Cash Flow: 19.95
Price / Sales: 2.12
EPS Growth
vs. Year Ago Period: 300.00%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 23.41%
vs. Previous Quarter: 1.60%
ROE
12/31/21 - -
09/30/21 - 9.59
06/30/21 - 8.03
ROA
12/31/21 - -
09/30/21 - 4.82
06/30/21 - 4.07
Current Ratio
12/31/21 - -
09/30/21 - 2.37
06/30/21 - 2.30
Quick Ratio
12/31/21 - -
09/30/21 - 1.26
06/30/21 - 1.24
Operating Margin
12/31/21 - -
09/30/21 - 6.35
06/30/21 - 5.59
Net Margin
12/31/21 - -
09/30/21 - -1.60
06/30/21 - -2.51
Pre-Tax Margin
12/31/21 - -
09/30/21 - -1.56
06/30/21 - -2.95
Book Value
12/31/21 - -
09/30/21 - 1.89
06/30/21 - 1.93
Inventory Turnover
12/31/21 - -
09/30/21 - 2.13
06/30/21 - 2.09
Debt-to-Equity
12/31/21 - -
09/30/21 - 0.56
06/30/21 - 0.52
Debt-to-Capital
12/31/21 - -
09/30/21 - 35.73
06/30/21 - 34.21
 

Powered by Zacks Investment Research ©